Welcoming you for any type of article submission for the upcoming issue on/before February 26, 2021.

Short Communication
Volume 5 Issue 7 - 2020
Metabolic Control in Patients with Premature Coronary Artery Disease
Martínez-Sánchez Froylan D and Juárez-Rojas Juan Gabriel*
Department of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Tlalpan, Mexico City, Mexico
*Corresponding Author: Juárez-Rojas Juan Gabriel, Department of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Tlalpan, Mexico City, Mexico.
Received: May 27, 2020; Published: June 20, 2020

Coronary artery disease (CAD) is the leading cause of mortality and disability around the world [1-3]. Although in previous decades the clinical and socioeconomical burden of CAD was mainly seen in older population, premature cardiovascular death and years of life lost due to cardiovascular disease have gradually increased since the end of the last century [1,3]. Besides quality of life is significantly reduced after a premature cardiovascular event, subjects at their fourth decade of life diminish their productive and psychosocial activities that adversely impacts all countries at every socioeconomical level [1,3]. Therefore, adequate secondary prevention of premature CAD will reduce the overwhelming costs to global health economies and reduces the risk for incident and recurrent cardiovascular events [4,5].


  1. Benjamin Emelia J., et al. “Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association”. Circulation10 (2019): e56-e528.
  2. “Mortality and Causes of Death Collaborators. “Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death (2015): 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015”. Lancet 388.10053 (2016): 1459-1544.
  3. Murray Christopher JL., et al. “Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010”. Lancet9859 (2012): 2197-223.
  4. Farkouh Michael E., et al. “Risk factor control for coronary artery disease secondary prevention in large randomized trials”. Journal of the American College of Cardiology15 (2013): 1607-1615.
  5. Brown Todd M., et al. “Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (Reasons for Geographic And Racial Differences in Stroke)”. Journal of the American College of Cardiology16 (2014): 1626-1633.
  6. Hansson Göran K. “Inflammation, atherosclerosis, and coronary artery disease”. The New England Journal of Medicine16 (2005): 1685-1695.
  7. Bäck M., et al. “Regulation of atherosclerotic plaque inflammation”. Journal of Internal Medicine5 (2015): 462-482.
  8. Poorzand Hoorak., et al. “Risk factors of premature coronary artery disease in Iran: A systematic review and meta-analysis”. European Journal of Clinical Investigation7 (2019): e13124.
  9. Mohammad Ameen Mosa., et al. “Prevalence and risk factors of premature coronary artery disease in patients undergoing coronary angiography in Kurdistan, Iraq”. BMC Cardiovascular Disorders 15 (2015): 155.
  10. Cole Jason H and Laurence S Sperling. “Premature coronary artery disease: clinical risk factors and prognosis”. Current Atherosclerosis Reports2 (2004): 121-125.
  11. Lloyd-Sherlock Peter., et al. “Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000-15”. The Lancet Global Health5 (2019): e604-e612.
  12. Jellinger Paul S., et al. “American Association Of Clinical Endocrinologists And American College Of Endocrinology Guidelines For Management Of Dyslipidemia And Prevention Of Cardiovascular Disease”. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists2 (2017): 1-87.
  13. Villarreal-Molina Teresa., et al. “The ABCA1 gene R230C variant is associated with decreased risk of premature coronary artery disease: the genetics of atherosclerotic disease (GEA) study”. PloS One 11 (2012): e49285.
  14. Martínez-Sánchez Froylan D., et al. “Prevalence of lipid control and factors associated with its poor attainment in patients with premature coronary artery disease”. Nutrition, Metabolism and Cardiovascular Diseases (2020).
  15. Whelton Paul K., et al. “2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines”. Journal of the American College of Cardiology19 (2018): e127-e248.
  16. American Diabetes Association. “10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2019”. Diabetes Care1 (2019): S103-S123.
  17. Yusuf Salim., et al. “Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study”. Lancet9438 (2004): 937-952.
  18. Fan Wenjun., et al. “Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative Registry”. Diabetes, Obesity and Metabolism5 (2019): 1121-1127.
  19. Schroeder Emily B., et al. “Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems”. Circulation Cardiovascular Quality and Outcomes5 (2012): 645-653.
  20. Rarau Patricia., et al. “Socio-economic status and behavioural and cardiovascular risk factors in Papua New Guinea: A cross-sectional survey”. PloS One 1 (2019): e0211068.
  21. Blom Dirk J., et al. “The challenge of multiple cardiovascular risk factor control outside Western Europe: Findings from the International cholesterol management Practice Study”. European Journal of Preventive Cardiology (2019): 2047487319871735.
  22. Kotseva Kornelia., et al. “Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry”. European Journal of Preventive Cardiology8 (2019): 824-835.
  23. Bertoni Alain G., et al. “Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study”. Journal of Diabetes and Its Complications1 (2008): 1-9.
  24. Jaffiol C., et al. “Impact of socioeconomic status on diabetes and cardiovascular risk factors: results of a large French survey”. Diabetes and Metabolism1 (2013): 56-62.
  25. Kitkungvan Danai., et al. “Low-density lipoprotein cholesterol target achievement in patients at high risk for coronary heart disease”. Journal of Clinical Lipidology4 (2010): 293-297.
Citation: Martínez-Sánchez Froylan D and Juárez-Rojas Juan Gabriel. “Metabolic Control in Patients with Premature Coronary Artery Disease”. EC Endocrinology and Metabolic Research 5.7 (2020): 06-09.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

March Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the March issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 07, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.